Carolina B. Moraes

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity.

Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols.

A comparative study of warheads for design of cysteine protease inhibitors.

Identification of di-substituted ureas that prevent growth of trypanosomes through inhibition of translation initiation.

Quantification of Parasite Loads by Automated Microscopic Image Analysis.

Expanding the Biological Application of Fluorescent Benzothiadiazole Derivatives: A Phenotypic Screening Strategy for Anthelmintic Drug Discovery Using .

Synthesis and structure-activity relationship of nitrile-based cruzain inhibitors incorporating a trifluoroethylamine-based P2 amide replacement.

Identification of Inhibitors to Sirtuins Based on Compounds Developed to Human Enzymes.

A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity.

Prospecting and Identifying Phyllanthus amarus Lignans with Antileishmanial and Antitrypanosomal Activity.

Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19.

The translational challenge in Chagas disease drug development.

Antiviral activity of var. extract and fractions against SARS-CoV-2.

Potential of plant extracts in targeting SARS-CoV-2 main protease: an and study.

Micro-Addition of Silver to Copper: One Small Step in Composition, a Change for a Giant Leap in Biocidal Activity.

Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander ().